NOVARTIS PHARMACEUTICALS CORPORATION - PLUVICTO 2026 - CLEVELAND VAMC

PIID: 36C25026F0205

Signed Date: Jan 20, 2026Effective Date: Jan 20, 2026End Date: Closes in 18 days

Award $

$617K

Vendor

NOVARTIS PHARMACEUTICALS CORPORATION

NAICS

325412

Signed Date

Jan 20, 2026

Key Details

Dollars Obligated

$617,296.68

Base & All Options

$617,296.68

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

EAST HANOVER, NJ, 079361080, CD-NJ-11

Description

PLUVICTO 2026 - CLEVELAND VAMC

Context & Analysis

On Jan 20, 2026, Department of Veterans Affairs obligated $617,296.68 to NOVARTIS PHARMACEUTICALS CORPORATION for pluvicto 2026 - cleveland vamc. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in EAST HANOVER, NJ. The contract is scheduled through Jun 30, 2026 — approximately 1 month remaining.